(AP) Johnson & Johnson’s Xarelto received an expanded indication as the Food and Drug Administration on Friday approved the blood thinner both to treat and to reduce the risk of recurrence of deep ...

Add Yahoo as a preferred source to see more of our stories on Google. Logo of German drugmaker Bayer AG in Leverkusen LONDON (Reuters) - Bayer's patent covering its best-selling blood thinner Xarelto ...

More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...

NEW ORLEANS (AP) — The pharmaceutical companies behind the widely advertised blood thinner Xarelto reached a $775 million settlement in 25,000 lawsuits alleging patients were not adequately warned ...

WASHINGTON (AP) — Federal regulators have denied Johnson & Johnson’s request to expand approval of its blood thinner Xarelto for a new use to prevent life-threatening blood clots in high-risk patients ...

Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the risk of ...

When Johnson & Johnson’s Xarelto entered the market in 2011 and Bristol Myers Squibb’s Eliquis did the same in 2013, list prices for the popular blood thinners were $218 and $250, respectively, for a ...

LONDON (Reuters) - Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto ...